```html

Ischemic Colitis – A Comprehensive Patient Guide

Overview

Ischemic colitis (IC) is inflammation and injury of the large intestine (colon) that occurs when blood flow to a segment of the colon is reduced or temporarily blocked. The reduced perfusion deprives the bowel wall of oxygen and nutrients, leading to inflammation, ulceration, and sometimes necrosis (tissue death).

IC is the most common form of intestinal ischemia, accounting for ≈50–60% of all cases of acute mesenteric ischemia <sup>1</sup>. It typically affects adults over the age of 60, but it can occur in younger individuals with specific risk factors (e.g., vasculitis, severe dehydration, or drug‑induced vasoconstriction).

In the United States, an estimated 15–20 cases per 100,000 people per year are diagnosed, with higher rates in females and in those with cardiovascular disease <sup>2</sup>. Although most episodes are mild and resolve with supportive care, severe cases can require surgery and carry a mortality of up to 10% <sup>3</sup>.

Symptoms

The presentation of ischemic colitis can be abrupt or develop over several hours. Because symptoms overlap with many other gastrointestinal disorders, a thorough history is essential.

Typical symptoms

• Abdominal pain or cramping – usually sudden, located in the left lower quadrant (LLQ) but can be diffuse.
• Bloody diarrhea – bright red or maroon stools; may contain mucus.
• Urgent or frequent bowel movements – often 3–6 episodes per day.
• Nausea and vomiting – less common than in small‑bowel ischemia.
• Rectal urgency – a feeling of needing to evacuate even when the colon is empty.

Atypical or less common symptoms

• Fever or chills (suggesting infection or severe inflammation).
• Weight loss (if chronic or recurrent episodes).
• Abdominal distention (in severe ischemia with paralytic ileus).
• Signs of systemic hypoperfusion: dizziness, rapid heartbeat, low blood pressure.

Causes and Risk Factors

Ischemic colitis results from a temporary reduction in blood flow to the colon. The colon’s blood supply has “watershed” zones—areas where two major arterial territories meet—that are especially vulnerable. The most common watershed zones are the splenic flexure (between the superior and inferior mesenteric arteries) and the rectosigmoid junction.

Primary mechanisms

• Hypoperfusion – sudden drops in systemic blood pressure (e.g., shock, severe dehydration, heart failure).
• Occlusive disease – atherosclerotic plaque or emboli that block arterial flow.
• Venous thrombosis – clotting within the mesenteric veins, reducing outflow.
• Medications – vasoconstrictors (e.g., cocaine, pseudoephedrine), digitalis, or chemotherapy agents.
• Inflammatory/autoimmune conditions – vasculitis (e.g., Takayasu, lupus) that narrows vessels.

Risk factors

• Age ≥ 60 years (vascular stiffness and atherosclerosis increase with age).
• Cardiovascular disease: hypertension, coronary artery disease, peripheral arterial disease.
• Congestive heart failure or atrial fibrillation (risk of emboli).
• Dehydration or severe volume loss (e.g., from vomiting, diarrhea, or diuretics).
• Smoking → accelerated atherosclerosis.
• Hypercoagulable states (e.g., factor V Leiden, antiphospholipid syndrome).
• Use of vasoconstrictive drugs (cocaine, ergotamines, over‑the‑counter nasal decongestants).
• Recent major surgery or trauma (blood loss and hypotension).

Diagnosis

Because symptoms mimic infections, inflammatory bowel disease, and diverticulitis, a systematic approach is crucial.

Initial evaluation

• History & physical exam – focus on pain location, stool characteristics, cardiovascular history, medication use, and recent events that could cause hypoperfusion.
• Vital signs – fever, tachycardia, hypotension may indicate severe disease.
• Laboratory studies – CBC (leukocytosis), BMP (electrolyte abnormalities), lactate (elevated in severe ischemia), inflammatory markers (CRP, ESR).

Imaging

• CT abdomen/pelvis with contrast – first‑line; findings include colonic wall thickening (often “target” or “halo” sign), pericolic fat stranding, and sometimes pneumatosis intestinalis.
• Mesenteric angiography – reserved for suspected arterial occlusion or when endovascular therapy is considered.
• Abdominal X‑ray – may show colonic dilatation or air‑fluid levels in advanced disease but is less sensitive.

Endoscopic assessment

• Colonoscopy (ideally within 24–48 h) – visualizes pale mucosa, ulcerations, or “dusky” areas; biopsies can rule out infection or IBD.
• Flexible sigmoidoscopy – useful when disease is limited to the left colon; less preparation needed.

Pathology

Biopsies typically reveal mucosal and submucosal hemorrhage, edema, and necrosis without the transmural involvement seen in Crohn’s disease.

Treatment Options

Treatment is tailored to severity—ranging from outpatient supportive care to urgent surgery.

Supportive care (mild to moderate disease)

• Fluid resuscitation – isotonic IV crystalloids to correct hypovolemia.
• Bowel rest – NPO (nothing by mouth) for 24–48 h; then advance to a low‑residue diet.
• Broad‑spectrum antibiotics (e.g., ciprofloxacin + metronidazole) if there is concern for bacterial translocation or perforation.
• Analgesia – acetaminophen preferred; avoid NSAIDs (may worsen mucosal injury).

Pharmacologic therapies for specific causes

• Anticoagulation – indicated if a thromboembolic source is identified (e.g., low‑molecular‑weight heparin transitioning to oral anticoagulants).
• Vasodilators – generally not used; however, in rare drug‑induced cases, discontinuation of the offending agent is essential.
• Management of underlying cardiac disease – optimize heart failure, control arrhythmias.

Surgical intervention (severe or complicated disease)

Indications include persistent bleeding, perforation, gangrene, or worsening sepsis despite medical therapy.

• Segmental colectomy – removal of the necrotic segment; primary anastomosis if patient is stable.
• Hartmann’s procedure – resection with end colostomy when anastomosis is unsafe.
• Laparoscopic vs. open approach – laparoscopic preferred when feasible, offering faster recovery.

Follow‑up care

• Repeat colonoscopy 4–6 weeks after discharge to ensure mucosal healing.
• Address modifiable risk factors (smoking cessation, blood pressure control).

Living with Ischemic Colitis

Even after recovery, patients may experience intermittent symptoms or anxiety about recurrence. Practical strategies help maintain quality of life.

Dietary tips

• Follow a low‑fiber, low‑fat diet during acute phases; gradually reintroduce fiber as tolerated.
• Stay well‑hydrated—aim for ≥ 2 L of water daily unless fluid restriction is ordered.
• Avoid large, greasy meals that can increase splanchnic demand.

Medication management

• Review all prescriptions and over‑the‑counter products with your physician—especially decongestants, NSAIDs, and vasoconstrictors.
• Adhere to antiplatelet or anticoagulant regimens if indicated for cardiovascular health.

Physical activity

• Engage in moderate aerobic exercise (e.g., walking, swimming) 150 min per week to improve circulation.
• Avoid activities that cause abrupt blood pressure drops, such as heavy lifting without proper breathing technique.

Monitoring and follow‑up

• Schedule routine visits every 3–6 months during the first year after an episode.
• Report any new abdominal pain, change in stool color, or unexplained weight loss promptly.

Prevention

Most cases are linked to modifiable cardiovascular and lifestyle factors.

• Control blood pressure and cholesterol – aim for <160/100 mmHg or lower; LDL <100 mg/dL.
• Quit smoking – reduces atherosclerotic progression.
• Stay hydrated – especially during hot weather, exercise, or illness.
• Manage diabetes – maintain HbA1c <7% to protect vascular health.
• Limit use of over‑the‑counter vasoconstrictors – opt for saline nasal sprays instead of phenylephrine.
• Regular cardiovascular screening – ECG, echocardiogram, or stress testing if you have risk factors.

Complications

If ischemic colitis is not promptly recognized or adequately treated, several serious complications can arise.

• Colonic necrosis and perforation – can lead to peritonitis and sepsis (mortality up to 30% in perforated cases).
• Chronic strictures – scar tissue may narrow the lumen, causing obstructive symptoms that sometimes require endoscopic dilation or surgery.
• Persistent diarrhea or incontinence – due to long‑standing mucosal damage.
• Sepsis – bacterial translocation through damaged mucosa.
• Recurrent ischemic episodes – especially if underlying vascular disease remains uncontrolled.

When to Seek Emergency Care

---

References:

1. Acosta, S. et al. “Ischemic colitis: Current concepts and emerging therapies.” Gastroenterology, 2021.
2. Ortiz, M. et al. “Epidemiology of ischemic colitis in the United States, 2010‑2020.” JAMA Surgery, 2022.
3. American College of Gastroenterology. “Guidelines for the Management of Acute Ischemic Colitis.” 2023.
4. Mayo Clinic. “Ischemic colitis.” Accessed May 2026.
5. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. “Ischemic Colitis Fact Sheet.” 2023.

```